Direct Oral Anticoagulants for Paediatrics and Inherited Thrombophilia: Why Not? | Biomedgrid

Direct oral anticoagulants (DOAC) are indicated in the treatment and prevention of venous thromboembolism (VTE). However, the use of DOAC in paediatrics VTE, and in patients with inherited thrombophilia remains controversial due to the paucity of available data. However, the efficacy of DOAC may be suitable in children and in patients with thrombophilia. Randomized clinical trials, which are currently underway, should offer definitive insight into the efficacy and safety profiles of DOAC in these patient populations